Jarno Hoekman
Jarno Hoekman
Innovation Studies Group, Utrecht University
Dirección de correo verificada de uu.nl - Página principal
TítuloCitado porAño
Research collaboration at a distance: Changing spatial patterns of scientific collaboration within Europe
J Hoekman, K Frenken, RJW Tijssen
Research Policy 39 (5), 662-673, 2010
The geography of collaborative knowledge production in Europe
J Hoekman, K Frenken, F Van Oort
The Annals of Regional Science 43 (3), 721-738, 2009
Spatial scientometrics: Towards a cumulative research program
K Frenken, S Hardeman, J Hoekman
Journal of informetrics 3 (3), 222-232, 2009
Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis
HJL Heerspink, TF Kröpelin, J Hoekman, D De Zeeuw
Journal of the American Society of Nephrology 26 (8), 2055-2064, 2015
Big Pharma, Little Science? A bibliometric perspective on big pharma’s R&D decline
I Rafols, M Hopkins, J Hoekman, P Nightingale, A Perianes-Rodriguez, ...
Technological Forecasting and Social Change, 2012
Acquisition of European research funds and its effect on international scientific collaboration
J Hoekman, T Scherngell, K Frenken, R Tijssen
Journal of economic geography 13 (1), 23-52, 2013
Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous …
HH Ampadu, J Hoekman, ML de Bruin, SN Pal, S Olsson, D Sartori, ...
Drug safety 39 (4), 335-345, 2016
Death of distance in science? A gravity approach to research collaboration
K Frenken, J Hoekman, S Kok, R Ponds, F van Oort, J van Vliet
Innovation networks, 43-57, 2009
Convergence in an enlarged Europe: the role of network cities
K Frenken, J Hoekman
Tijdschrift voor economische en sociale geografie 97 (3), 321-326, 2006
Use of the conditional marketing authorization pathway for oncology medicines in Europe
J Hoekman, WPC Boon, JC Bouvy, HC Ebbers, JP de Jong, ML De Bruin
Clinical Pharmacology & Therapeutics 98 (5), 534-541, 2015
The Geographical Distribution of Leadership in Globalized Clinical Trials
J Hoekman, K Frenken, D de Zeeuw, HL Heerspink
PLOS ONE 7 (10), e45984, 2012
Collaboration networks as carriers of knowledge spillovers
J Hoekman, K Frenken, F Van Oort
KITeS Working Papers 222, 2008
Characteristics and follow‐up of postmarketing studies of conditionally authorized medicines in the EU
J Hoekman, TT Klamer, AK Mantel‐Teeuwisse, HGM Leufkens, ...
British journal of clinical pharmacology 82 (1), 213-226, 2016
The Importance of Short‐Term Off‐Target Effects in Estimating the Long‐Term Renal and Cardiovascular Protection of Angiotensin Receptor Blockers
PA Smink, Y Miao, MJC Eijkemans, SJL Bakker, I Raz, HH Parving, ...
Clinical Pharmacology & Therapeutics 95 (2), 208-215, 2014
Towards a European research area
K Frenken, J Hoekman, FG van Oort
Achtergronden 3, 2007
What drives university research performance? An analysis using the CWTS Leiden Ranking data
K Frenken, GJ Heimeriks, J Hoekman
Journal of Informetrics 11 (3), 859-872, 2017
Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers
B Schievink, D De Zeeuw, PA Smink, D Andress, JJ Brennan, B Coll, ...
European journal of preventive cardiology 23 (7), 758-768, 2016
A prediction of the renal and cardiovascular efficacy of aliskiren in ALTITUDE using short-term changes in multiple risk markers
PA Smink, J Hoekman, DE Grobbee, MJC Eijkemans, HH Parving, ...
European journal of preventive cardiology 21 (4), 434-441, 2014
Spatial scientometrics and scholarly impact: A review of recent studies, tools, and methods
K Frenken, J Hoekman
Measuring scholarly impact, 127-146, 2014
European infrastructure networks and regional innovation in science-based technologies
S Vinciguerra, K Frenken, J Hoekman, F van Oort
Economics of Innovation and New Technology 20 (5), 517-537, 2011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20